Compare Stocks: MIST, HELP, TLRY, and SPRY

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HELP Cybin	$11.61	$6.37	$3.76 ▼ $11.62	$811.19M	0.55	1.99 million shs	1.73 million shs
MIST Milestone Pharmaceuticals	$1.22	$1.24	$1.00 ▼ $3.06	$151.89M	0.98	1.07 million shs	981,860 shs
SPRY ARS Pharmaceuticals	$6.16	$7.88	$4.91 ▼ $17.90	$611.71M	0.98	2.45 million shs	2.16 million shs
TLRY Tilray Brands	$4.57	$4.58	$3.67 ▼ $23.20	$622.43M	1.9	4.84 million shs	3.41 million shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HELP Cybin	0.00%	+48.47%	+69.00%	+127.65%	+1,160,999,900.00%
MIST Milestone Pharmaceuticals	0.00%	+9.91%	-4.69%	-35.79%	-18.67%
SPRY ARS Pharmaceuticals	0.00%	+20.08%	-22.42%	-28.37%	-64.80%
TLRY Tilray Brands	0.00%	+0.66%	+3.39%	-17.06%	-29.55%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HELP Cybin	$11.61	$6.37	$3.76 ▼ $11.62	$811.19M	0.55	1.99 million shs	1.73 million shs
MIST Milestone Pharmaceuticals	$1.22	$1.24	$1.00 ▼ $3.06	$151.89M	0.98	1.07 million shs	981,860 shs
SPRY ARS Pharmaceuticals	$6.16	$7.88	$4.91 ▼ $17.90	$611.71M	0.98	2.45 million shs	2.16 million shs
TLRY Tilray Brands	$4.57	$4.58	$3.67 ▼ $23.20	$622.43M	1.9	4.84 million shs	3.41 million shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HELP Cybin	0.00%	+48.47%	+69.00%	+127.65%	+1,160,999,900.00%
MIST Milestone Pharmaceuticals	0.00%	+9.91%	-4.69%	-35.79%	-18.67%
SPRY ARS Pharmaceuticals	0.00%	+20.08%	-22.42%	-28.37%	-64.80%
TLRY Tilray Brands	0.00%	+0.66%	+3.39%	-17.06%	-29.55%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
HELP Cybin	3.00	Buy	$45.25	289.75% Upside
MIST Milestone Pharmaceuticals	2.67	Moderate Buy	$7.25	494.26% Upside
SPRY ARS Pharmaceuticals	2.50	Moderate Buy	$28.20	357.79% Upside
TLRY Tilray Brands	2.50	Moderate Buy	$11.00	140.70% Upside

Current Analyst Ratings Breakdown

Latest MIST, HELP, TLRY, and SPRY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/31/2026	TLRY Tilray Brands	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong-Buy
7/27/2026	HELP Cybin	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Overweight	$16.00
7/14/2026	MIST Milestone Pharmaceuticals	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/14/2026	TLRY Tilray Brands	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$7.00 ➝ $5.00
7/13/2026	MIST Milestone Pharmaceuticals	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
6/25/2026	SPRY ARS Pharmaceuticals	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Outperform	$25.00 ➝ $24.00
6/1/2026	SPRY ARS Pharmaceuticals	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
5/28/2026	SPRY ARS Pharmaceuticals	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$12.00 ➝ $30.00
5/15/2026	SPRY ARS Pharmaceuticals	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
5/15/2026	MIST Milestone Pharmaceuticals	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
5/14/2026	MIST Milestone Pharmaceuticals	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Overweight	$8.00 ➝ $7.00

(Data available from 8/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
HELP Cybin	N/A	N/A	N/A	N/A	$4.49 per share	N/A
MIST Milestone Pharmaceuticals	$1.55M	97.99	N/A	N/A	$0.39 per share	3.13
SPRY ARS Pharmaceuticals	$98.99M	6.18	N/A	N/A	$1.16 per share	5.31
TLRY Tilray Brands	$915.45M	0.68	N/A	N/A	$13.68 per share	0.33

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
HELP Cybin	-$148M	-$4.23	N/A	N/A	N/A	N/A	-68.27%	-58.26%	N/A
MIST Milestone Pharmaceuticals	-$63.06M	-$0.68	N/A	N/A	N/A	N/A	-339.33%	-61.79%	8/12/2026 (Estimated)
SPRY ARS Pharmaceuticals	-$171.30M	-$2.01	N/A	N/A	N/A	-200.00%	-153.61%	-60.85%	8/13/2026 (Estimated)
TLRY Tilray Brands	-$121.40M	-$1.08	N/A	N/A	N/A	-13.11%	-7.76%	-5.59%	10/8/2026 (Estimated)

Latest MIST, HELP, TLRY, and SPRY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2026	Q2 2026	SPRY ARS Pharmaceuticals	-$0.4766	N/A	N/A	N/A	$31.33 million	N/A
8/12/2026	Q2 2026	MIST Milestone Pharmaceuticals	-$0.18	N/A	N/A	N/A	$0.82 million	N/A
7/28/2026	Q4 2026	TLRY Tilray Brands	-$0.0120	-$0.43	-$0.4180	-$0.43	$246.30 million	$281.71 million
5/15/2026	Q1 2026	SPRY ARS Pharmaceuticals	-$0.53	-$0.61	-$0.08	-$0.61	$22.20 million	$22.68 million
5/13/2026	Q1 2026	MIST Milestone Pharmaceuticals	$0.06	-$0.20	-$0.26	-$0.20	$30.12 million	$0.24 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
HELP Cybin	N/A	N/A	N/A	N/A	N/A
MIST Milestone Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
SPRY ARS Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
TLRY Tilray Brands	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
HELP Cybin	N/A	9.52	9.52
MIST Milestone Pharmaceuticals	1.61	9.18	9.09
SPRY ARS Pharmaceuticals	2.79	4.94	4.77
TLRY Tilray Brands	0.22	2.21	1.37

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
HELP Cybin	17.94%
MIST Milestone Pharmaceuticals	86.18%
SPRY ARS Pharmaceuticals	68.16%
TLRY Tilray Brands	9.35%

Insider Ownership

Company	Insider Ownership
HELP Cybin	15.00%
MIST Milestone Pharmaceuticals	5.03%
SPRY ARS Pharmaceuticals	33.80%
TLRY Tilray Brands	0.84%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
HELP Cybin	50	69.87 million	59.39 million	N/A
MIST Milestone Pharmaceuticals	30	124.50 million	118.24 million	Optionable
SPRY ARS Pharmaceuticals	90	99.30 million	65.74 million	Optionable
TLRY Tilray Brands	3,595	136.20 million	135.06 million	Optionable

MIST, HELP, TLRY, and SPRY Headlines

Recent News About These Companies

Top Cannabis Stocks To Follow Today - August 7th

August 9 at 4:05 AM | americanbankingnews.com

Tilray Brands (NASDAQ:TLRY) General Counsel Mitchell Gendel Buys 2,500 Shares

August 8 at 7:36 AM | insidertrades.com

Tilray Brands (TLRY) Gets Fresh Attention As Mollo Lite Launch Fuels The Value Debate

August 8 at 3:18 AM | finance.yahoo.com

Tilray Brands, Inc. (NASDAQ:TLRY) Receives Consensus Recommendation of "Moderate Buy" from Analysts

August 8 at 2:13 AM | marketbeat.com

Tilray Brands (NASDAQ:TLRY) Trading Up 2.9% - Should You Buy?

August 7 at 5:39 PM | marketbeat.com

Why Tilray Brands (NASDAQ:TLRY) Is The Name Cannabis Watchers Are Buzzing About Today

August 7 at 5:03 PM | kalkinemedia.comK

Mitchell Gendel Acquires 2,500 Shares of Tilray Brands (NASDAQ:TLRY) Stock

August 7 at 11:06 AM | marketbeat.com

Best Cannabis Stocks Worth Watching - August 5th

August 7 at 4:05 AM | americanbankingnews.com

Stocks in play: Tilray Brands Inc.

August 6, 2026 | ca.finance.yahoo.com

Tilray Brands Expands THC Beverage Innovation with the Launch of Mollo Lite Blackberry Lemon Seltzer Multi-Pack

August 6, 2026 | finance.yahoo.com

Tilray Brands Expands THC Beverage Innovation with the Launch of Mollo Lite Blackberry Lemon Seltzer Multi-Pack

August 6, 2026 | financialpost.comF

Tilray Brands (NASDAQ:TLRY) Shares Down 4.5% - Should You Sell?

August 5, 2026 | marketbeat.com

3 Top Canadian Marijuana Stock Picks To Add Value To Your Portfolio

August 5, 2026 | marijuanastocks.comM

Tilray Brands (NASDAQ:TLRY) Steps Into the Penny-Stock Spotlight as Cannabis Names Stir

August 5, 2026 | kalkinemedia.comK

Denise Faltischek Purchases 2,500 Shares of Tilray Brands (NASDAQ:TLRY) Stock

August 5, 2026 | insidertrades.com

Tilray Brands (NASDAQ:TLRY) Trading Up 2.2% After Analyst Upgrade

August 5, 2026 | americanbankingnews.com

Why Is Tilray (NASDAQ:TLRY) a Nasdaq Composite Watchlist Stock?

August 4, 2026 | kalkinemedia.comK

Insider Buying: Tilray Brands (NASDAQ:TLRY) CFO Purchases $46,200.00 in Stock

August 4, 2026 | marketbeat.com

Tilray Brands (NASDAQ:TLRY) Insider Buys 2,500 Shares

August 4, 2026 | marketbeat.com

Tilray Brands Posted Record Numbers for Fiscal 2026. Here's Why That's Not Enough to Make the Stock a Buy

August 4, 2026 | fool.com

Best Cannabis Stocks To Keep An Eye On - August 1st

August 4, 2026 | americanbankingnews.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

MIST, HELP, TLRY, and SPRY Company Descriptions

Cybin NASDAQ:HELP

$11.61 0.00 (0.00%)

Closing price 08/7/2026 04:00 PM Eastern

Extended Trading

$10.81 -0.80 (-6.88%)

As of 05:25 AM Eastern

Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a discovery-phase phenethylamine derivative to treat neuroinflammation and psychiatric conditions. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.

Milestone Pharmaceuticals NASDAQ:MIST

$1.22 0.00 (0.00%)

Closing price 08/7/2026 04:00 PM Eastern

Extended Trading

$1.24 +0.02 (+1.64%)

As of 04:30 AM Eastern

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans, as well as with the Montreal Heart Institute, the WCN network, and other research centers. The company was incorporated in 2003 and is headquartered in Montréal, Canada.

ARS Pharmaceuticals NASDAQ:SPRY

$6.16 0.00 (0.00%)

Closing price 08/7/2026 04:00 PM Eastern

Extended Trading

$5.89 -0.27 (-4.35%)

As of 05:28 AM Eastern

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.

Tilray Brands NASDAQ:TLRY

$4.57 0.00 (0.00%)

Closing price 08/7/2026 04:00 PM Eastern

Extended Trading

$4.59 +0.02 (+0.46%)

As of 05:22 AM Eastern

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MIST, HELP, TLRY, and SPRY Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MIST, HELP, TLRY, and SPRY Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MIST, HELP, TLRY, and SPRY Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

MIST, HELP, TLRY, and SPRY Company Descriptions

Cybin NASDAQ:HELP

Milestone Pharmaceuticals NASDAQ:MIST

ARS Pharmaceuticals NASDAQ:SPRY

Tilray Brands NASDAQ:TLRY

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MIST, HELP, TLRY, and SPRY Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MIST, HELP, TLRY, and SPRY Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MIST, HELP, TLRY, and SPRY Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

MIST, HELP, TLRY, and SPRY Company Descriptions

Cybin NASDAQ:HELP

Milestone Pharmaceuticals NASDAQ:MIST

ARS Pharmaceuticals NASDAQ:SPRY

Tilray Brands NASDAQ:TLRY

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools